Vergelijking
Bremelanotide vs. Terlipressin
Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.
Identiteit
Categorie
Onderzoek (overig)
Onderzoek (overig)
CAS-nr.
189691-06-3
14636-12-5
Molecuulmassa
1025.18 g/mol
1227.37 g/mol
Halfwaardetijd
2.7 h
geen gegevens
Sequentie
Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OHgeen gegevens
Werkingsmechanisme
Bremelanotide
Bremelanotide is a cyclic peptide that binds non-selectively to melanocortin receptors (MC1R through MC5R) — with highest affinity at MC4R in the central nervous system. The precise role of MC4R activation in sexual behaviour is not fully understood; animal data show effects on hypothalamic circuits. Peripheral effects (blood pressure, hyperpigmentation) are attributed to MC1R/MC2R.
Terlipressin
Terlipressin is slowly converted in the body to lysine-vasopressin by cleavage of the three N-terminal glycyl residues (reservoir effect) and activates V1 receptors. The splanchnic vasoconstriction improves renal perfusion in hepatorenal syndrome.
Bewijsbasis
Hoogste bewijs
Humane RCT
Humane RCT
Studies
5
1
waarvan bij mensen
5
1
Geregistreerde effecten
3
2
Openstaande tegenstrijdigheden
1
0
Gedocumenteerde bijwerkingen
2
1
Juridische status
Volledige vermeldingen
Frequently asked questions
- What is the difference between Bremelanotide and Terlipressin?
- Bremelanotide is classified as "Onderzoek (overig)", while Terlipressin is classified as "Onderzoek (overig)". Bremelanotide: Synthetic cyclic heptapeptide acting as a non-selective melanocortin-receptor agonist. FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in pre-menopausal women. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Bremelanotide or Terlipressin?
- The highest available evidence level is "Humane RCT" for Bremelanotide and "Humane RCT" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Bremelanotide and Terlipressin in Germany and the United States?
- Duitsland: Bremelanotide — Niet goedgekeurd, Terlipressin — Op recept. Verenigde Staten: Bremelanotide — Op recept, Terlipressin — Op recept. These are factual summaries with source and review date on the individual pages.